Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1999-11-17
2000-10-31
Seaman, D. Margaret
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514314, 514318, 546159, 546192, 546193, C07D21538, C07D21168, A61K 31445, A61K 3147, L07D21108
Patent
active
06140344&
ABSTRACT:
This invention relates to certain piperidine quaternary salts of Formula (I) ##STR1## that are CCR-3 receptor antagonists, pharmaceutical compositions containing them, methods for their use and methods for preparing these compounds.
REFERENCES:
patent: 4559349 (1985-12-01), Storni
patent: 5143923 (1992-09-01), Hrib et al.
patent: 5317020 (1994-05-01), Emonds-Alt et al.
patent: 5541201 (1996-07-01), Carr et al.
patent: 5728835 (1998-03-01), Aoki
U.S. patent application SN 09/134,013, Filing date Aug. 14, 1998, Cyclic Amine Derivatives CCR-3 Receptor Antagonists, Gong, et al. (Assignee Syntex (U.S.A.) Inc); Docket No. R0029B-REG.
Gong Leyi
Kertesz Denis John
Smith David Berard
Wilhelm Robert Stephen
Bansal Rekha
Peries Rohan
Seaman D. Margaret
Syntex (U.S.A.) Inc.
LandOfFree
4-aroylpiperidine derivatives-CCR-3 receptor antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 4-aroylpiperidine derivatives-CCR-3 receptor antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 4-aroylpiperidine derivatives-CCR-3 receptor antagonists will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2052157